{"id":"NCT01342913","sponsor":"GlaxoSmithKline","briefTitle":"A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))","officialTitle":"A 12-week Study to Evaluate the 24 Hour Pulmonary Function of Fluticasone Furoate (FF)/Vilanterol Inhalation Powder (FF/VI Inhalation Powder) Once Daily Compared With Salmeterol/Fluticasone Propionate (FP) Inhalation Powder Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-02-01","primaryCompletion":"2011-10-01","completion":"2011-10-19","firstPosted":"2011-04-27","resultsPosted":"2013-07-30","lastUpdate":"2018-08-31"},"enrollment":528,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"Fluticasone Furoate 100mcg/Vilanterol 25mcg","otherNames":[]},{"type":"DRUG","name":"Fluticaosne Propionate 500mcg/Salmeterol 50mcg","otherNames":[]}],"arms":[{"label":"Fluticasone Furoate/Vilanterol","type":"EXPERIMENTAL"},{"label":"Fluticasone Propionate/Salmeterol","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the 24-hour spirometry effect (FEV1) of Fluticasone Furoate/Vilanterol 100/25mcg once daily compared with Salmeterol/Fluticasone Propionate 50/500mcg twice daily over a 12-week treatmen period in subjects with COPD.","primaryOutcome":{"measure":"Change From Baseline Trough in 24-hour Weighted-mean FEV1 on Treatment Day 84","timeFrame":"Baseline and Day 84","effectByArm":[{"arm":"Salmeterol/FP 50/500 µg BID","deltaMin":0.108,"sd":0.0145},{"arm":"FF/VI 100/25 µg QD","deltaMin":0.13,"sd":0.0148}],"pValues":[{"comp":"OG000 vs OG001","p":"0.282"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":17},"locations":{"siteCount":66,"countries":["Belgium","France","Germany","Italy","Philippines","Poland","Russia","Spain","Ukraine"]},"refs":{"pmids":["24114969"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":262},"commonTop":["Headache","Nasopharyngitis","Back pain"]}}